ILAEの2025年度のエピレプシー発作分類の受け入れと認識:神経科医と神経科リジデントの調査
Alvaro Sanchez-Larsen1, Antía Moreira Villanueva2, Luísa Panadés-de Oliveira3
1Department of Neurology, Albacete University Hospital Complex, Albacete, Spain.
Epilepsy & behavior : E&B
|September 2, 2025
まとめ
神経学者は,国際抗連盟 (ILAE) の更新された発作分類について,異論を唱えています. 変更を支持する人もいれば,新しい2025年ILAE分類のタイミングと実用的な利点に疑問を抱いている人もいます.
科学分野:
- 神経学
- エピレプト学
背景:
- 国際 病 連合 (ILAE) は,発作 の 分類 を 定期 的 に 修正 し,理解 の 進歩 を 反映 し て い ます.
- 以前のILAE分類は,エピレプシーの管理における臨床実践と研究を導きました.
研究 の 目的:
- 最新のILAE発作分類アップデート (2025) に関する神経学者と神経学のリジデントの認識を評価する.
- ニューロロジック専門家の異なるグループにおける新しい分類の受け入れ,認識された利益,および予想された採用を理解する.
主な方法:
- スペイン語圏の10カ国の神経学者と住民に匿名でオンライン調査が行われました
- この調査には,人口統計とILAEの検挙分類に関する意見に関する23の項目が含まれていました.
- データを分析するために,記述的および二元的な方法を含む統計的分析が使用されました.
主要な成果:
- 2017年のILAE分類は,124人の回答者の48.8%が好むシステムでした.
- 56.5%が分類の更新を支持し,53.3%が修正が早すぎると考えていた.
- エピレプトロジストは,より批判的だった一般神経科医とレジデントと比較して,2025年更新に向けてより好意的 (61.9%) であった.
結論:
- 2025年のILAE発作分類は 神経科医と患者の間で意見が分かれていて タイミングと有用性については懸念がある.
- 2017年の分類は,最も広く受け入れられているバージョンです.
- 混雑した反応にもかかわらず,新しいILAE分類が臨床実務で広く採用されると予想されています.
関連する概念動画
Seizures: Classification
584
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
584
Epilepsy and Seizures: Overview
275
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
275
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
445
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
445
Electroconvulsive Therapy
182
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
182
Diagnostic and Statistical Manual of Mental Disorders (DSM)
141
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
141
Antiepileptic Drugs: GABAergic Pathway Potentiators
635
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
635


